Cardiovascular complications of androgen deprivation therapy for prostate cancer Journal Article


Authors: Gupta, D.; Salmane, C.; Slovin, S.; Steingart, R. M.
Article Title: Cardiovascular complications of androgen deprivation therapy for prostate cancer
Abstract: Prostate cancer is a common hormone-sensitive malignancy, and androgen deprivation therapy (ADT) is a cornerstone of therapy in advanced disease. The most important and controversial of ADT side effects is cardiovascular (CV) toxicity. Prospective trials have demonstrated that ADT increases CV risk by lowering insulin sensitivity, causing dyslipidemia, and causing weight gain thus mimicking metabolic syndrome. Retrospective data suggests that ADT increases CV risk; however, data on cardiovascular mortality is equivocal. This discrepancy can be explained by study design limitations and selection bias inherent to post hoc analysis of trials not designed to study CV outcomes. Despite the adverse CV and metabolic sequelae of ADT, little data is available for optimal cardiac screening or management in these patients. The short-term CV risk is higher in patients who have had CV events in the year prior to starting ADT. A careful discussion of risk and benefit of ADT must take place with patients with pre-existing CV disease prior to initiating hormonal therapy. The duration of ADT must be considered. We recommend diligent pretherapy screening and optimization of cardiac risk factors and close surveillance especially within the first year of ADT. © 2017, Springer Science+Business Media New York.
Keywords: mortality; prostate cancer; cardiovascular disease; atherosclerosis; androgen deprivation therapy; mechanism
Journal Title: Current Treatment Options in Cardiovascular Medicine
Volume: 19
Issue: 8
ISSN: 1092-8464
Publisher: Springer Healthcare  
Date Published: 2017-08-01
Start Page: 61
Language: English
DOI: 10.1007/s11936-017-0563-1
PROVIDER: scopus
PUBMED: 28653290
DOI/URL:
Notes: Review -- Export Date: 2 August 2017 -- Source: Scopus
Altmetric
Citation Impact
MSK Authors
  1. Susan Slovin
    250 Slovin
  2. Richard M Steingart
    172 Steingart
  3. Dipti Gupta
    55 Gupta